Systemic light chain amyloidosis

V Sanchorawala - New England Journal of Medicine, 2024 - Mass Medical Soc
Key Points Systemic Light Chain Amyloidosis Immunoglobulin light chain (AL) amyloidosis
is a rare disease that occurs when a plasma cell disorder produces monoclonal light chains …

Systemic immunoglobulin light chain amyloidosis

G Merlini, A Dispenzieri, V Sanchorawala… - Nature reviews Disease …, 2018 - nature.com
Systemic immunoglobulin light chain amyloidosis is a protein misfolding disease caused by
the conversion of immunoglobulin light chains from their soluble functional states into highly …

AL amyloidosis: advances in diagnostics and treatment

R Ryšavá - Nephrology Dialysis Transplantation, 2019 - academic.oup.com
AL amyloidosis (light chain; previously also called primary amyloidosis) is a systemic
disease characterized by an amyloid deposition process affecting many organs, and which …

Cardiac biomarkers of heart failure in chronic kidney disease

X Han, S Zhang, Z Chen, BK Adhikari, Y Zhang… - Clinica Chimica …, 2020 - Elsevier
Heart failure remains a continuing threat to patients with chronic kidney disease (CKD).
Although various heart failure biomarkers have been applied for early detection, diagnosis …

Growth differentiation factor 15: A novel biomarker with high clinical potential

S Desmedt, V Desmedt, L De Vos… - Critical Reviews in …, 2019 - Taylor & Francis
Initially considered as a macrophage inhibitor (macrophage inhibitory cytokine-1), growth
differentiation factor 15 (GDF-15) has been identified as a pleiotropic protein that plays key …

Use of biomarkers to diagnose and manage cardiac amyloidosis

V Castiglione, M Franzini, A Aimo… - European journal of …, 2021 - Wiley Online Library
Amyloidoses are characterized by the tissue accumulation of misfolded proteins into
insoluble fibrils. The two most common types of systemic amyloidosis result from the …

GDF15 is an epithelial-derived biomarker of idiopathic pulmonary fibrosis

Y Zhang, M Jiang, M Nouraie… - … of Physiology-Lung …, 2019 - journals.physiology.org
Idiopathic pulmonary fibrosis (IPF) is the most common and devastating of the interstitial
lung diseases. Epithelial dysfunction is thought to play a prominent role in disease …

Light chain amyloidosis: epidemiology, staging, and prognostication

KR Baker - Methodist DeBakey Cardiovascular Journal, 2022 - pmc.ncbi.nlm.nih.gov
Amyloidosis is a disorder of protein misfolding and metabolism in which insoluble fibrils are
deposited in various tissues, causing organ dysfunction and eventually death. Out of the 60 …

Systemic AL amyloidosis: current approaches to diagnosis and management

D Fotiou, MA Dimopoulos, E Kastritis - Hemasphere, 2020 - journals.lww.com
AL amyloidosis is characterized by a low-level expansion of an indolent, small plasma cell
clone that produces amyloidogenic light chains. Amyloid aggregates or preceding …

Growth differentiation factor 15 (GDF-15) in kidney diseases

C Delrue, R Speeckaert, JR Delanghe… - Advances in Clinical …, 2023 - Elsevier
Abstract Growth differentiation factor-15 (GDF-15) is a GDF subfamily member with potential
kidney protective functions. Its nephroprotective activity is associated with both inflammation …